Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 31 REF: 4Z-C-121034CAS: 247068-84-4	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 69 REF: 4Z-P-196076CAS: 1023594-50-4	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 45 REF: 4Z-N-066063	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 46 REF: 4Z-P-196053CAS: 2375089-01-1	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 78 REF: 4Z-C-121081	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 65 REF: 4Z-O-032070CAS: 169141-21-3	- - -	To inquire	Tue 10 Dec 24
Fulvestrant REF: TM-T2146CAS: 129453-61-8	100% - 99.87%	49.00 €~733.00 €	Tue 10 Dec 24
Fulvestrant Impurity 3 REF: 4Z-F-3116CAS: 1621885-81-1	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 1 REF: 4Z-E-068009CAS: 1443331-78-9	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 85 REF: 4Z-P-196097	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 16 REF: 4Z-N-066030	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 86 REF: 4Z-P-196098	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 30 REF: 4Z-E-068043CAS: 915087-24-0	- - -	To inquire	Tue 10 Dec 24
N2-Nitroso Levofolinic Acid REF: 4Z-F-068034	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 35 REF: 4Z-O-032040	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 50 REF: 4Z-C-121053	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity C REF: 4Z-E-068008CAS: 179232-29-2	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 40 REF: 4Z-P-196047	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 62 REF: 4Z-C-121065	- - -	To inquire	Tue 10 Dec 24
Abiraterone-d4 N-Oxide REF: 4Z-A-8244	- - -	To inquire	Tue 10 Dec 24

10mg		49.00 €
25mg		72.00 €
50mg		114.00 €
1mL*10mM (DMSO)		57.00 €

Cancer treatment

Carfilzomib Impurity 31

Ref: 4Z-C-121034

Palbociclib Impurity 69

Ref: 4Z-P-196076

Nintedanib Impurity 45

Ref: 4Z-N-066063

Palbociclib Impurity 46

Ref: 4Z-P-196053

Carfilzomib Impurity 78

Ref: 4Z-C-121081

Olaparib Impurity 65

Ref: 4Z-O-032070

Fulvestrant

Ref: TM-T2146

Fulvestrant Impurity 3

Ref: 4Z-F-3116

Enzalutamide Impurity 1

Ref: 4Z-E-068009

Palbociclib Impurity 85

Ref: 4Z-P-196097

Nintedanib Impurity 16

Ref: 4Z-N-066030

Palbociclib Impurity 86

Ref: 4Z-P-196098

Enzalutamide Impurity 30

Ref: 4Z-E-068043

N2-Nitroso Levofolinic Acid

Ref: 4Z-F-068034

Olaparib Impurity 35

Ref: 4Z-O-032040

Carfilzomib Impurity 50

Ref: 4Z-C-121053

Enzalutamide Impurity C

Ref: 4Z-E-068008

Palbociclib Impurity 40

Ref: 4Z-P-196047

Carfilzomib Impurity 62

Ref: 4Z-C-121065

Abiraterone-d4 N-Oxide

Ref: 4Z-A-8244